WOMEN'S HEALTH SCIENCE
There is a restricted range of treatments available for the common and problematic condition known as atrophic vulvovaginitis, with readily available over the counter remedies including moisturizing and lubricating gels, and prescription treatments involving steroid hormones. The former have limited efficacy and no real curative powers, and the latter are surrounded in controversy of public opinion.
Many women therefore remain untreated with this difficult condition. Fear of hormones is possibly the main reason for this, some of it justified, as there is a large group of women who are disallowed from using systemic hormone replacement treatment due to risk of cancer or past cancer.
Atrophic vaginitis can cause pain, discomfort, and sexual dysfunction with concomitant damage to relationships. Thinning of the mucosa and change to the vaginal pH induced by estrogen deficiency predispose the urogenital tract to infection and mechanical weakness. Treatment with oestrogen is often effective but this is not an appropriate treatment for a large group of women, nor a desired treatment for those concerned about the potentially deleterious effects of exogenous hormones.
Up to 40% of post menopausal women suffer symptoms of atrophic vaginitis including decreased lubrication, fragile mucosa which can tear or become inflamed, irritation which extends to the urethra, frequent infections and reduction in pelvic support and continence. 35% of women have some level of incontinence relating to vaginal health. Hyaluronic acid has been shown to be helpful in alleviating the symptoms of vulvovaginal atrophy while simple humectants have not been shown to help. Our company is committed to providing non hormonal vaginal products that relieve these symptoms.